Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Preventing low oxygen during sedated TAVI using SuperNO2VA versus standard oxygen

Official title: Comparison of SuperNO₂VA™ Nasal Mask and Conventional Nasal Oxygen Therapy in Preventing Hypoxia During Sedation for TAVI Procedures in Geriatric Patients

Run by Ankara Bilkent Sehir Hastanesi · NCT07006064 · Data updated 2026-11-12

This will test whether the SuperNO2VA nasal mask prevents low oxygen and poor breathing better than standard oxygen for people 65 and older having TAVI under sedation.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment100 (estimated)
SponsorAnkara Bilkent Sehir Hastanesi
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedMay 15, 2025
Main results expectedJanuary 25, 2026
Study endsFebruary 25, 2026
Registry record updatedAugust 29, 2025
Trial IDNCT07006064 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 65 or older who are scheduled for TAVI under sedation and are not expected to require endotracheal intubation.

Probably not a fit

Patients planned for general anesthesia with intubation, those with a tracheostomy or history of prolonged intubation, or patients undergoing TAVI with only local anesthesia are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Older patients scheduled for TAVI under sedation will receive either the SuperNO2VA nasal mask or conventional oxygen delivery, with continuous monitoring including end-tidal CO2 and pulse oximetry. The trial enrolls patients aged 65 and older and excludes those with prior prolonged intubation, tracheostomy, or planned endotracheal intubation. Investigators will compare rates of hypoxemia and episodes of hypoventilation detected by capnography and oxygenation measures between groups. The primary aim is earlier detection and prevention of sedative-related respiratory depression to improve procedural safety in this high-risk population.

Why it matters

Potential benefit: If successful, the SuperNO2VA approach could reduce episodes of hypoxia and undetected hypoventilation during sedated TAVI, lowering complications for older patients.

How similar studies have gone: Capnography and nasal positive-pressure support have improved detection and prevention of hypoventilation in other sedated procedures, but data specifically on SuperNO2VA use during TAVI are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 65 years and older who are scheduled for TAVI under sedation will be included in the study.

Exclusion Criteria:

* History of prolonged intubation
* History of tracheostomy
* Patients who are planned to undergo endotracheal intubation during the procedure
* Patients undergoing TAVI under local anesthesia

Where it's running

  • Ankara Bilkent City Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.